MICROVISION, INC. (MVIS) — SEC Filings

Latest SEC filings for MICROVISION, INC. (MVIS), explained in plain English.

Sentiment Overview: 2 bearish, 31 neutral, 1 mixed

Recent Filings (34)

• MicroVision Files 8-K with Exhibits — 8-K · 2026-04-07T08:45:51-04:00 [neutral] Risk: low
  On April 7, 2026, MicroVision, Inc. filed an 8-K report detailing its financial statements and exhibits. The filing includes various graphic files, likely prese
• MicroVision Announces Board & Executive Compensation Changes — 8-K · 2025-11-21T00:00:00.000Z [neutral] Risk: medium
  MicroVision, Inc. announced on November 17, 2025, a change in its board of directors and executive compensation arrangements. Specifically, the company reported
• MicroVision Narrows Losses, Boosts Liquidity Amid Revenue Dip — 10-Q · 2025-11-12T00:00:00.000Z [mixed] Risk: medium
  MicroVision, Inc. reported a net loss of $14.2 million for the three months ended September 30, 2025, a slight improvement from the $15.5 million net loss in th
• MicroVision Reports Director, Officer Changes & Compensation — 8-K · 2025-09-04T00:00:00.000Z [neutral] Risk: low
  MicroVision, Inc. filed an 8-K on September 4, 2025, reporting changes related to its board of directors and officers, including elections and appointments. The
• MicroVision's Losses Widen Amid Continued Equity Dilution — 10-Q · 2025-08-08T00:00:00.000Z [bearish] Risk: high
  MICROVISION, INC. reported a net loss of $17.5 million for the three months ended June 30, 2025, a significant increase from the $13.2 million net loss in the s
• MicroVision, Inc. Files 8-K Report — 8-K · 2025-08-07T00:00:00.000Z [neutral] Risk: low
  On August 7, 2025, MicroVision, Inc. filed an 8-K report detailing its financial results and operations. The filing indicates the company's fiscal year ends on
• MicroVision Announces Director Changes and New CTO Compensation — 8-K · 2025-07-24T00:00:00.000Z [neutral] Risk: medium
  On July 22, 2025, MicroVision, Inc. filed an 8-K report detailing the departure of director Dr. Alexander J. R. Smith and the election of new director Dr. Sarah
• MicroVision Files 8-K: Shareholder Votes, Financials, Bylaw Updates — 8-K · 2025-06-06T00:00:00.000Z [neutral] Risk: medium
  On June 6, 2025, MicroVision, Inc. filed an 8-K report detailing several key events. The company submitted matters to a vote of its security holders, likely rel
• MicroVision Supplement to June 6, 2025 Shareholder Meeting Proxy — DEFA14A · 2025-06-05T00:00:00.000Z [neutral] Risk: low
  MicroVision, Inc. filed a Definitive Additional Materials (DEFA14A) on June 5, 2025, supplementing its proxy statement for the Annual Meeting of Shareholders sc
• MicroVision Appoints BDO USA as New Auditor — 8-K · 2025-06-04T00:00:00.000Z [neutral] Risk: low
  On June 4, 2025, MicroVision, Inc. filed an 8-K report to disclose changes in its certifying accountant. The company has appointed BDO USA, LLP as its new indep
• MicroVision Files Proxy Materials for 2025 Shareholder Meeting — DEFA14A · 2025-05-28T00:00:00.000Z [neutral] Risk: low
  MicroVision, Inc. filed a Definitive Additional Materials document on May 28, 2025, related to its 2025 Annual Meeting of Shareholders. This filing is an amendm
• MicroVision, Inc. Files Q1 2025 10-Q Report — 10-Q · 2025-05-12T00:00:00.000Z [neutral] Risk: medium
  MicroVision, Inc. filed its 10-Q report for the period ending March 31, 2025. The filing details financial performance and operational updates for the first qua
• MicroVision Files DEF 14A, Details Executive Compensation — DEF 14A · 2025-04-28T00:00:00.000Z [neutral] Risk: medium
  MicroVision, Inc. filed a DEF 14A on April 28, 2025, detailing executive compensation and other corporate matters for the fiscal year ending December 31, 2024.
• MicroVision, Inc. Files 2024 Annual Report — 10-K · 2025-03-26T00:00:00.000Z [neutral] Risk: medium
  MicroVision, Inc. filed its 10-K for the fiscal year ending December 31, 2024, on March 26, 2025. The company, headquartered in Redmond, WA, operates in the ele
• MicroVision, Inc. Files 8-K Report — 8-K · 2025-03-24T00:00:00.000Z [neutral] Risk: low
  On March 24, 2025, MicroVision, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updat
• MicroVision, Inc. Files Material Definitive Agreement 8-K — 8-K · 2025-02-03T00:00:00.000Z [neutral] Risk: medium
  On February 3, 2025, MicroVision, Inc. filed an 8-K report detailing a material definitive agreement. The filing does not provide specific details on the agreem
• SC 13G/A Filing — SC 13G/A · 2024-11-08T00:00:00.000Z [neutral]
• MicroVision Files Q3 2024 10-Q Report — 10-Q · 2024-11-07T00:00:00.000Z [neutral] Risk: medium
  MicroVision, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the third quarter and the first nine month
• SC 13G/A Filing — SC 13G/A · 2024-10-22T00:00:00.000Z [neutral]
• MicroVision Enters Credit Agreement, Issues Equity — 8-K · 2024-10-15T00:00:00.000Z [neutral] Risk: medium
  On October 14, 2024, MicroVision, Inc. entered into a Material Definitive Agreement, specifically a credit agreement with an unnamed lender. This agreement crea
• MicroVision Reports Director Changes and Compensatory Arrangements — 8-K · 2024-09-27T00:00:00.000Z [neutral] Risk: low
  MicroVision, Inc. filed an 8-K on September 27, 2024, reporting changes in its board of directors and certain officers, along with updates to compensatory arran
• MicroVision, Inc. Files Q2 2024 10-Q Report — 10-Q · 2024-08-08T00:00:00.000Z [neutral] Risk: medium
  MicroVision, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported financial results for the second quarter and the first half of the ye
• MicroVision, Inc. Files 8-K on Financials — 8-K · 2024-08-07T00:00:00.000Z [neutral] Risk: medium
  MicroVision, Inc. filed an 8-K on August 7, 2024, reporting on its results of operations and financial condition, and providing financial statements and exhibit
• MicroVision Appoints New CFO, David D. Allen — 8-K · 2024-07-25T00:00:00.000Z [neutral] Risk: medium
  MicroVision, Inc. announced on July 24, 2024, the appointment of David D. Allen as Chief Financial Officer, effective immediately. Allen will also serve as Prin
• MicroVision Sells Laser Scanning Business for $22M — 8-K · 2024-06-10T00:00:00.000Z [neutral] Risk: medium
  MicroVision, Inc. announced on June 4, 2024, that it has entered into a definitive agreement to sell its laser scanning business to an affiliate of Accel-KKR fo
• MicroVision, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · 2024-05-10T00:00:00.000Z [neutral] Risk: medium
  MICROVISION, INC. (MVIS) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. MicroVision, Inc. reported financial results for the quarter ended March
• MicroVision, Inc. Files 8-K on Financials — 8-K · 2024-05-09T00:00:00.000Z [neutral] Risk: low
  MicroVision, Inc. filed an 8-K on May 9, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhi
• MicroVision, Inc. Files Definitive Proxy Statement (DEF 14A) — DEF 14A · 2024-04-29T00:00:00.000Z [neutral] Risk: low
  MICROVISION, INC. (MVIS) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. MicroVision, Inc. filed a Definitive Proxy Statement (DEF 14A) on Apr
• MicroVision Appoints New CFO, Grants Stock Options — 8-K · 2024-04-08T00:00:00.000Z [neutral] Risk: medium
  MicroVision, Inc. announced on April 8, 2024, the appointment of Steven A. Johnson as Chief Financial Officer, effective April 15, 2024. Johnson will receive an
• MicroVision Enters and Terminates Material Agreements — 8-K · 2024-03-05T00:00:00.000Z [neutral] Risk: medium
  On March 5, 2024, MicroVision, Inc. entered into a Material Definitive Agreement and also terminated a Material Definitive Agreement. The filing includes financ
• MicroVision, Inc. Files 2023 Annual Report on Form 10-K — 10-K · 2024-02-29T00:00:00.000Z [neutral] Risk: medium
  MICROVISION, INC. (MVIS) filed a Annual Report (10-K) with the SEC on February 29, 2024. MicroVision, Inc. reported its 2023 fiscal year results ending December
• MicroVision Files 8-K for Financial Results Disclosure — 8-K · 2024-02-28T00:00:00.000Z [neutral] Risk: low
  MicroVision, Inc. filed an 8-K on February 28, 2024, to report on "Results of Operations and Financial Condition" and "Financial Statements and Exhibits." This
• Vanguard Amends MicroVision Stake, Remains Passive Investor — SC 13G/A · 2024-02-13T00:00:00.000Z [neutral] Risk: low
  The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, indicating its beneficial ownership of MicroVision Inc. common stoc
• BlackRock Cuts MicroVision Stake to 9.0% — SC 13G/A · 2024-01-24T00:00:00.000Z [bearish]
  BlackRock, Inc. filed an amended SC 13G/A on January 24, 2024, indicating its ownership of 7,009,879 shares of MicroVision, Inc. common stock as of December 31,